Zydus receives final approval from the USFDA for Clindamycin Phosphate and Benzoyl Peroxide Gel
Deepthi | Myequity news | Date : 29-12-2018 17:25:00 IST
Zydus Cadila has received the final approval from the USFDA to market Clindamycin Phosphate and Benzoyl Peroxide Gel, (US RLD —DUAC® Gel), 1.2%/5%. It will be manufactured at the group’s Topical manufacturing facility at Ahmedabad. About Zydus Cadila:
This combination medication is used to treat a certain type of acne (inflammatory acne vulgaris). It helps to decrease the number of acne pimples. Clindamycin is an antibiotic that stops the growth of acne-causing bacteria. Benzoyl peroxide can also stop the growth of bacteria as well as reduce oil production in the skin.
Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.